These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 20236105)

  • 1. Association study of four key folliculogenesis genes in polycystic ovary syndrome.
    Sproul K; Jones MR; Mathur R; Azziz R; Goodarzi MO
    BJOG; 2010 May; 117(6):756-60. PubMed ID: 20236105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of AMH and its receptor SNP in the pathogenesis of PCOS.
    Wang F; Niu WB; Kong HJ; Guo YH; Sun YP
    Mol Cell Endocrinol; 2017 Jan; 439():363-368. PubMed ID: 27664518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-Müllerian hormone gene polymorphism is associated with androgen levels in Chinese polycystic ovary syndrome patients with insulin resistance.
    Zheng MX; Li Y; Hu R; Wang FM; Zhang XM; Guan B
    J Assist Reprod Genet; 2016 Feb; 33(2):199-205. PubMed ID: 26732661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genes involved in initial follicle recruitment may be associated with age at menopause.
    Voorhuis M; Broekmans FJ; Fauser BC; Onland-Moret NC; van der Schouw YT
    J Clin Endocrinol Metab; 2011 Mar; 96(3):E473-9. PubMed ID: 21193543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A functional anti-mullerian hormone gene polymorphism is associated with follicle number and androgen levels in polycystic ovary syndrome patients.
    Kevenaar ME; Laven JS; Fong SL; Uitterlinden AG; de Jong FH; Themmen AP; Visser JA
    J Clin Endocrinol Metab; 2008 Apr; 93(4):1310-6. PubMed ID: 18230658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased frequency of the anti-mullerian-inhibiting hormone receptor 2 (AMHR2) 482 A>G polymorphism in women with polycystic ovary syndrome: relationship to luteinizing hormone levels.
    Georgopoulos NA; Karagiannidou E; Koika V; Roupas ND; Armeni A; Marioli D; Papadakis E; Welt CK; Panidis D
    J Clin Endocrinol Metab; 2013 Nov; 98(11):E1866-70. PubMed ID: 23969185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations of Polymorphisms in Anti-Müllerian Hormone (AMH Ile49Ser) and its Type II Receptor (AMHRII -482 A>G) on Reproductive Outcomes and Polycystic Ovary Syndrome: a Systematic Review and Meta-Analysis.
    Pabalan N; Montagna E; Singian E; Tabangay L; Jarjanazi H; Barbosa CP; Bianco B
    Cell Physiol Biochem; 2016; 39(6):2249-2261. PubMed ID: 27832628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-Müllerian hormone level is associated with vitamin D receptor polymorphisms in women with polycystic ovary syndrome.
    Szafarowska M; Dziech E; Kaleta B; Kniotek M; Rogowski A; Segiet-Święcicka A; Jerzak M
    J Assist Reprod Genet; 2019 Jun; 36(6):1281-1289. PubMed ID: 31089932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional Genetic Variation in the Anti-Müllerian Hormone Pathway in Women With Polycystic Ovary Syndrome.
    Gorsic LK; Dapas M; Legro RS; Hayes MG; Urbanek M
    J Clin Endocrinol Metab; 2019 Jul; 104(7):2855-2874. PubMed ID: 30786001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysregulation of the Anti-Müllerian Hormone System by Steroids in Women With Polycystic Ovary Syndrome.
    Pierre A; Taieb J; Giton F; Grynberg M; Touleimat S; El Hachem H; Fanchin R; Monniaux D; Cohen-Tannoudji J; di Clemente N; Racine C
    J Clin Endocrinol Metab; 2017 Nov; 102(11):3970-3978. PubMed ID: 28938480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of FSHR, AMH, and AMHRII variants in women with polycystic ovary syndrome.
    Czeczuga-Semeniuk E; Jarząbek K; Galar M; Kozłowski P; Sarosiek NA; Zapolska G; Wołczyński S
    Endocrine; 2015 Apr; 48(3):1001-4. PubMed ID: 25012254
    [No Abstract]   [Full Text] [Related]  

  • 12. Abnormal expression of growth differentiation factor 9 and bone morphogenetic protein 15 in stimulated oocytes during maturation from women with polycystic ovary syndrome.
    Wei LN; Liang XY; Fang C; Zhang MF
    Fertil Steril; 2011 Aug; 96(2):464-8. PubMed ID: 21669410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variants in the ACVR1 gene are associated with AMH levels in women with polycystic ovary syndrome.
    Kevenaar ME; Themmen AP; van Kerkwijk AJ; Valkenburg O; Uitterlinden AG; de Jong FH; Laven JS; Visser JA
    Hum Reprod; 2009 Jan; 24(1):241-9. PubMed ID: 18854405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-Müllerian hormone (AMH), inhibin-α, growth differentiation factor 9 (GDF9), and bone morphogenic protein-15 (BMP15) mRNA and protein are influenced by photoperiod-induced ovarian regression and recrudescence in Siberian hamster ovaries.
    Shahed A; Young KA
    Mol Reprod Dev; 2013 Nov; 80(11):895-907. PubMed ID: 23877969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum Concentrations of Oocyte-Secreted Factors BMP15 and GDF9 During IVF and in Women With Reproductive Pathologies.
    Riepsamen AH; Chan K; Lien S; Sweeten P; Donoghoe MW; Walker G; Fraison EHJ; Stocker WA; Walton KL; Harrison CA; Ledger WL; Robertson DM; Gilchrist RB
    Endocrinology; 2019 Oct; 160(10):2298-2313. PubMed ID: 31211369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Change and significance of growth differentiation factor 9 and bone morphogenetic protein expression during oocyte maturation in polycystic ovary syndrome patients with ovarian stimulation].
    Wei LN; Fang C; Huang R; Li LL; Zhang MF; Liang XY
    Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):818-22. PubMed ID: 23302121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Bone Morphogenetic Protein 15 Up-Regulates the Anti-Müllerian Hormone Receptor Expression in Granulosa Cells.
    Pierre A; Estienne A; Racine C; Picard JY; Fanchin R; Lahoz B; Alabart JL; Folch J; Jarrier P; Fabre S; Monniaux D; di Clemente N
    J Clin Endocrinol Metab; 2016 Jun; 101(6):2602-11. PubMed ID: 27070094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum GDF9 and BMP15 as potential markers of ovarian function in women with and without polycystic ovary syndrome.
    Riepsamen AH; Donoghoe MW; Indran IR; Hechtman L; Robertson DM; Gilchrist RB; Ledger WL; Yong EL
    Clin Endocrinol (Oxf); 2023 Apr; 98(4):567-577. PubMed ID: 36372988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GDF9 and BMP15 Expressions and Fine Structure Changes During Folliculogenesis in Polycystic Ovary Syndrome.
    Karagül Mİ; Aktaş S; Coşkun Yılmaz B; Yılmaz M; Orekici Temel G
    Balkan Med J; 2018 Jan; 35(1):43-54. PubMed ID: 28903889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced and delayed expression of GDF9 and BMP15 in ovarian tissues from women with polycystic ovary syndrome.
    Wei LN; Huang R; Li LL; Fang C; Li Y; Liang XY
    J Assist Reprod Genet; 2014 Nov; 31(11):1483-90. PubMed ID: 25172094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.